1990 MAIN STREET, SARASOTA, FL
Reg. FD, Other Events
Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation
Doses First Patient in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury
Oragenics, Inc. Schedules 2025 Annual Meeting for June 29, 2026
Explores Expansion of CNS Platform Pursuing Acquisition of Assets in Brain Health, Recovery, and Neuroprotection
Amendment to At-the-Market Sales Agreement with Dawson James Securities
Investor Presentation
CEO Compensation Increase and Stock Option Award for Janet Huffman
Q1
FY 2025
Q3
Q2
FY 2024
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Amended Registration Statement for Securities
S-1
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload
Deregistration Letter